Exploration into antithrombotic treatment of coronary heart disease and its perspective in China
10.11855/j.issn.0577-7402.2015.04.01
- Author:
Ya-Ling HAN
1
Author Information
1. Department of Cardiology, General Hospital of Shenyang Command
- Publication Type:Journal Article
- Keywords:
Angioplasty;
Coronary disease;
Thrombolytic therapy
- From:
Medical Journal of Chinese People's Liberation Army
2015;40(4):255-261
- CountryChina
- Language:Chinese
-
Abstract:
Antithrombotic therapy is the cornerstone of the treatment of coronary heart disease. To optimize antithrombotic therapy is one of ongoing efforts made by cardiovascular physicians. The randomized controlled clinical research of high quality in the field of antithrombotic therapy for coronary heart disease is still lacking in our country at present, and it become an important problem to be urgently solved in China. As there are studies with rich research data on antithrombotic therapy for cardiovascular disease domestically, and the differences in the problems involved between eastern and western populations, a preliminary exploration had been done in 2012 in the research center where the author is serving. This paper chiefly reviews the problems of major concern in antithrombotic therapy, our present situation, and treatment strategy based on our experience in clinical research for years.
